These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37095076)

  • 1. Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2.
    Liu Z; Lee PG; Krez N; Lam KH; Liu H; Przykopanski A; Chen P; Yao G; Zhang S; Tremblay JM; Perry K; Shoemaker CB; Rummel A; Dong M; Jin R
    Nat Commun; 2023 Apr; 14(1):2338. PubMed ID: 37095076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SV2 is the protein receptor for botulinum neurotoxin A.
    Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER
    Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
    Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER
    Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.
    Weisemann J; Stern D; Mahrhold S; Dorner BG; Rummel A
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1.
    Mahrhold S; Bergström T; Stern D; Dorner BG; Åstot C; Rummel A
    Biochem J; 2016 Sep; 473(17):2645-54. PubMed ID: 27313224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors.
    Azzaz F; Hilaire D; Fantini J
    Chem Biol Interact; 2023 Mar; 373():110384. PubMed ID: 36754227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
    Peng L; Tepp WH; Johnson EA; Dong M
    PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
    Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
    Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
    Rummel A
    Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG-Syt1-SV2 plasma membrane nanocluster for synaptic vesicle entry.
    Joensuu M; Syed P; Saber SH; Lanoue V; Wallis TP; Rae J; Blum A; Gormal RS; Small C; Sanders S; Jiang A; Mahrhold S; Krez N; Cousin MA; Cooper-White R; Cooper-White JJ; Collins BM; Parton RG; Balistreri G; Rummel A; Meunier FA
    EMBO J; 2023 Jul; 42(13):e112095. PubMed ID: 37226896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding.
    Gustafsson R; Zhang S; Masuyer G; Dong M; Stenmark P
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29649119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.
    Benoit RM; Frey D; Hilbert M; Kevenaar JT; Wieser MM; Stirnimann CU; McMillan D; Ceska T; Lebon F; Jaussi R; Steinmetz MO; Schertler GF; Hoogenraad CC; Capitani G; Kammerer RA
    Nature; 2014 Jan; 505(7481):108-11. PubMed ID: 24240280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves.
    Mahrhold S; Rummel A; Bigalke H; Davletov B; Binz T
    FEBS Lett; 2006 Apr; 580(8):2011-4. PubMed ID: 16545378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the interaction of botulinum neurotoxin a with its neuronal receptor SV2C.
    Li X; Brunner C; Wu Y; Leka O; Schneider G; Kammerer RA
    Toxicon; 2020 Feb; 175():36-43. PubMed ID: 31783045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
    J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E.
    Mahrhold S; Strotmeier J; Garcia-Rodriguez C; Lou J; Marks JD; Rummel A; Binz T
    Biochem J; 2013 Jul; 453(1):37-47. PubMed ID: 23621114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A.
    Yamagata A; Ito K; Suzuki T; Dohmae N; Terada T; Shirouzu M
    Nat Commun; 2024 Apr; 15(1):3027. PubMed ID: 38637505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A.
    Yao G; Zhang S; Mahrhold S; Lam KH; Stern D; Bagramyan K; Perry K; Kalkum M; Rummel A; Dong M; Jin R
    Nat Struct Mol Biol; 2016 Jul; 23(7):656-62. PubMed ID: 27294781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR; Barbieri JT
    Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three players in the 'toxic affair' between botulinum neurotoxin type A and neurons.
    Rossetto O; Pirazzini M; Montecucco C
    Trends Neurosci; 2023 Sep; 46(9):695-697. PubMed ID: 37385877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.